Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yohei Doi

Showing results (261-270 of 493) with videos related to

Pageof 50
Sort By:
International Journal of Antimicrobial Agents|February 28, 2024
Levofloxacin-induced MexS mutation triggers imipenem-relebactam resistance in a KPC-producing Pseudomonas aeruginosaLeilei Wang, Xun Zhou, Yanyan Lu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 4, 2009
Clinical features and molecular epidemiology of CMY-type beta-lactamase-producing Escherichia coliHanna E Sidjabat, David L Paterson, Zubair A Qureshi, et al.
Antimicrobial Stewardship & Healthcare Epidemiology : ASHE|November 29, 2023
The impact of carbapenem shortage and stewardship countermeasures on antimicrobial practice at a tertiary care centerYuichi Kouyama, Yuki Uehara, Akane Takamatsu, et al.
Computational and Structural Biotechnology Journal|October 26, 2022
Whole-genome analysis of carbapenem-resistant <i>Acinetobacter baumannii</i> from clinical isolates in Southern ThailandArnon Chukamnerd, Kamonnut Singkhamanan, Virasakdi Chongsuvivatwong, et al.
Journal of Clinical Pharmacology|May 20, 2011
Microdosing clinical study: pharmacokinetic, pharmacogenomic (SLCO2B1), and interaction (grapefruit juice) profiles of celiprolol following the oral microdose and therapeutic doseIchiro Ieiri, Yohei Doi, Kazuya Maeda, et al.
Infection Control and Hospital Epidemiology|November 20, 2020
Risk factors for the development of infections associated with carbapenemase-producing <i>Enterobacteriaceae</i> among previously colonized patients: A retrospective cohort studyAdriana Jimenez, Kristopher Fennie, L Silvia Munoz-Price, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 8, 2022
Efficacy and Safety of Ensitrelvir in Patients With Mild-to-Moderate Coronavirus Disease 2019: The Phase 2b Part of a Randomized, Placebo-Controlled, Phase 2/3 StudyHiroshi Mukae, Hiroshi Yotsuyanagi, Norio Ohmagari, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|February 9, 2025
Clinical and microbiological characteristics of skin and soft tissue infections of the extremities with bacteremia in patients with malignancyTaisuke Enokida, Sohei Harada, Koh Okamoto, et al.
Therapeutic Advances in Infectious Disease|April 28, 2025
Ensitrelvir as a novel treatment option for mild-to-moderate COVID-19: a narrative literature reviewHiroshi Mukae, Hiroshi Yotsuyanagi, Norio Ohmagari, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 6, 2009
Interspecies spread of Klebsiella pneumoniae carbapenemase gene in a single patientHanna E Sidjabat, Fernanda P Silveira, Brian A Potoski, et al.
Pageof 50

Showing results (261-270 of 493) with videos related to

Sort By:
Pageof 50
International Journal of Antimicrobial Agents|February 28, 2024
Levofloxacin-induced MexS mutation triggers imipenem-relebactam resistance in a KPC-producing Pseudomonas aeruginosaLeilei Wang, Xun Zhou, Yanyan Lu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 4, 2009
Clinical features and molecular epidemiology of CMY-type beta-lactamase-producing Escherichia coliHanna E Sidjabat, David L Paterson, Zubair A Qureshi, et al.
Antimicrobial Stewardship & Healthcare Epidemiology : ASHE|November 29, 2023
The impact of carbapenem shortage and stewardship countermeasures on antimicrobial practice at a tertiary care centerYuichi Kouyama, Yuki Uehara, Akane Takamatsu, et al.
Computational and Structural Biotechnology Journal|October 26, 2022
Whole-genome analysis of carbapenem-resistant <i>Acinetobacter baumannii</i> from clinical isolates in Southern ThailandArnon Chukamnerd, Kamonnut Singkhamanan, Virasakdi Chongsuvivatwong, et al.
Journal of Clinical Pharmacology|May 20, 2011
Microdosing clinical study: pharmacokinetic, pharmacogenomic (SLCO2B1), and interaction (grapefruit juice) profiles of celiprolol following the oral microdose and therapeutic doseIchiro Ieiri, Yohei Doi, Kazuya Maeda, et al.
Infection Control and Hospital Epidemiology|November 20, 2020
Risk factors for the development of infections associated with carbapenemase-producing <i>Enterobacteriaceae</i> among previously colonized patients: A retrospective cohort studyAdriana Jimenez, Kristopher Fennie, L Silvia Munoz-Price, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 8, 2022
Efficacy and Safety of Ensitrelvir in Patients With Mild-to-Moderate Coronavirus Disease 2019: The Phase 2b Part of a Randomized, Placebo-Controlled, Phase 2/3 StudyHiroshi Mukae, Hiroshi Yotsuyanagi, Norio Ohmagari, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|February 9, 2025
Clinical and microbiological characteristics of skin and soft tissue infections of the extremities with bacteremia in patients with malignancyTaisuke Enokida, Sohei Harada, Koh Okamoto, et al.
Therapeutic Advances in Infectious Disease|April 28, 2025
Ensitrelvir as a novel treatment option for mild-to-moderate COVID-19: a narrative literature reviewHiroshi Mukae, Hiroshi Yotsuyanagi, Norio Ohmagari, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 6, 2009
Interspecies spread of Klebsiella pneumoniae carbapenemase gene in a single patientHanna E Sidjabat, Fernanda P Silveira, Brian A Potoski, et al.
Pageof 50